Abstract
The following unique case demonstrates an episode of acute dyskinesia secondary to oral baclofen toxicity. We discuss an 80-year-old man with a history of Stage III chronic kidney disease, coronary artery disease, diabetes and stroke who presented to the Emergency Department with new onset of behavioral changes and irregular jerking movements. The patient had been recently prescribed baclofen 10mg twice daily for a back strain he suffered; he subsequently was admitted to the hospital, and his symptoms resolved within 48 hours of admission and discontinuance of baclofen.
References
El-Husseini A, Sabucedo A, Lamarche J, Courville C, Peguero A. Baclofen toxicity in patients with advanced nephropathy: proposal for new labeling. Am J Nephrol. 2011;34(6):491–5.
Cruz HG, Ivanova T, Lunn ML, Stoffel M, Slesinger PA, Lüscher C. Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system. Nat Neurosci. 2004;7(2):153–9.
Ryan DM, Blumenthal FS. Baclofen-induced dyskinesia. Arch Phys Med Rehabil. 1993;74(7):766–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed Consent
Consent for publication of this case was obtained and provided to the journal in accordance with JMT policy.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Sources of Funding
The authors have no outside support information.
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s13181-017-0604-x.
Rights and permissions
About this article
Cite this article
Niehaus, M.T., Elliott, N.C. & Katz, K.D. Baclofen Toxicity Causing Acute, Reversible Dyskinesia. J. Med. Toxicol. 12, 406–407 (2016). https://doi.org/10.1007/s13181-016-0556-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-016-0556-6